Stay updated on Lebrikizumab Long-term Safety Efficacy AD Clinical Trial

Sign up to get notified when there's something new on the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Taiwan site listing now specifies Taoyuan City rather than Taoyuan, clarifying the exact location.
    Difference
    0.0%
    Check dated 2026-05-07T09:42:40.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision: v3.5.3 now appears, replacing Revision: v3.5.2. This indicates a version update to the page’s documentation or release notes rather than changes to study data or core content.
    Difference
    0.0%
    Check dated 2026-04-30T03:21:21.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page’s software/site revision indicator was updated from v3.5.0 to v3.5.2, with no visible changes to the study information.
    Difference
    0.0%
    Check dated 2026-04-22T18:16:53.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.0, replacing the previous revision v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-25T00:45:29.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The revision tag was updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-10T14:25:33.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-17T02:29:06.000Z thumbnail image

Stay in the know with updates to Lebrikizumab Long-term Safety Efficacy AD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lebrikizumab Long-term Safety Efficacy AD Clinical Trial page.